Literature DB >> 12873567

Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association.

Reza Shaker1, Donald O Castell, Philip S Schoenfeld, Stuart J Spechler.   

Abstract

OBJECTIVE: Although a large body of information exists about the prevalence of gastroesophageal reflux disease (GERD) in general, available data specifically addressing nocturnal reflux are limited. Because nocturnal acid reflux is reported to be associated with more severe injuries such as esophagitis and stricture, as well as adenocarcinoma of the esophagus, a better understanding of the prevalence and impact of nighttime heartburn as a sign of nocturnal acid reflux events can have significant potential management implications. The aims of this study were to determine the prevalence of nighttime heartburn and reflux-attributed supraesophageal symptoms among patients with GERD; and the impact of nighttime heartburn on sleep and several activities of daily living that could affect quality of life.
METHODS: A nationwide telephone survey of 1000 adults experiencing heartburn at least once a week was conducted by the Gallup Organization on behalf of the American Gastroenterological Association.
RESULTS: Altogether, 79% of respondents reported experiencing heartburn at night. Among those, 75% reported that symptoms affected their sleep, 63% believed that heartburn negatively affected their ability to sleep well, and 40% believed that nocturnal heartburn impaired their ability to function the following day. Of the 791 respondents with nighttime heartburn, 71% reported taking over-the-counter medicine for it, but only 29% of these rated this approach extremely effective. Forty-one percent reported trying prescription medicines, and 49% of these rated this approach extremely effective.
CONCLUSIONS: Nighttime heartburn occurs in a large majority of adults with GERD, resulting in sleeping difficulties and impaired next-day function. The expected result from implemented therapy for heartburn is not achieved by a sizable percentage of patients.

Entities:  

Mesh:

Year:  2003        PMID: 12873567     DOI: 10.1111/j.1572-0241.2003.07531.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  88 in total

Review 1.  Newer therapies for gastroesophageal reflux disease: numb, burn, or stitch?

Authors:  J Jailwala; R Shaker
Journal:  Curr Gastroenterol Rep       Date:  2001-06

2.  Gastroesophageal reflux disease symptoms and dietary behaviors are significant correlates of short sleep duration in the general population: the Nagahama Study.

Authors:  Kimihiko Murase; Yasuharu Tabara; Yoshimitsu Takahashi; Shigeo Muro; Ryo Yamada; Kazuya Setoh; Takahisa Kawaguchi; Hiroshi Kadotani; Shinji Kosugi; Akihiro Sekine; Takeo Nakayama; Michiaki Mishima; Tsutomu Chiba; Kazuo Chin; Fumihiko Matsuda
Journal:  Sleep       Date:  2014-11-01       Impact factor: 5.849

3.  Management of nighttime gastroesophageal reflux disease.

Authors:  William C Orr
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-08

4.  Bravo pH Testing On and Off Treatment With Immediate-Release Omeprazole: A Review of Findings Presented at the 71st Annual Scientific Meeting of the American College of Gastroenterology October 20-25, 2006 Las Vegas, Nev.

Authors:  Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-01

5.  Comparative efficacy of rabeprazole and pantoprazole in the control of nocturnal Acid output and intragastric acidity.

Authors:  Hank S Wang; David S Oh; Ariana Anderson; Jose Nieto; Phuong Tien; Gordon Ohning; Joseph R Pisegna
Journal:  Gut Liver       Date:  2008-06-30       Impact factor: 4.519

6.  Gastroesophageal reflux disease: Important considerations for the older patients.

Authors:  Maxwell M Chait
Journal:  World J Gastrointest Endosc       Date:  2010-12-16

7.  Daytime intragastric acid control: post hoc analyses of esomeprazole 20 mg and over-the-counter proton-pump inhibitors.

Authors:  Philip Katz; Peter J Kahrilas; David A Johnson; Tore Lind; Kerstin Röhss; Barry Traxler; Vincent Hugo; John Dent
Journal:  Therap Adv Gastroenterol       Date:  2015-11       Impact factor: 4.409

8.  Night-time symptoms and their impact on sleep in patients with gastroesophageal reflux disease who have a partial response to proton pump inhibitors: a qualitative patient interview study.

Authors:  Anna Rydén; Mona Martin; Katarina Halling; Anna Niklasson
Journal:  Patient       Date:  2013       Impact factor: 3.883

9.  Morbidity associated with sleep disorders in primary care: a longitudinal cohort study.

Authors:  Mari-Ann Wallander; Saga Johansson; Ana Ruigómez; Luis A García Rodríguez; Roger Jones
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

10.  Gastroesophageal reflux disease as an etiology of sleep disturbance in subjects with insomnia and minimal reflux symptoms: a pilot study of prevalence and response to therapy.

Authors:  Nicholas J Shaheen; Ryan D Madanick; Maha Alattar; Douglas R Morgan; Paris H Davis; Joseph A Galanko; Melissa B Spacek; Bradley V Vaughn
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.